medicine
A Study of DS-9606a in Patients With Advanced Solid Tumors: A Phase 1, First-in-Human Study of DS-9606a in Patients With Tumor Types Known to Express Claudin-6 (CLDN6)
2023年2月1日
hamada3
https://quercus-mikasa.com/wp-content/uploads/2019/06/IMG_2564.jpg
Be the change you wish to see in the world.
2023年2月1日 水曜日 曇り
https://clinicaltrials.gov/ct2/show/NCT05394675 よ …